Skip Navigation

Correction for Herrmann et al., Cardiovasc Res 63 (4) 756.
Cardiovascular Research 2004 61(1):11-21; doi:10.1016/j.cardiores.2003.09.033
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Corrigendum (v63,p756)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Herrmann, J.
Right arrow Articles by Lerman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herrmann, J.
Right arrow Articles by Lerman, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

The ubiquitin–proteasome system in cardiovascular diseases—a hypothesis extended

Joerg Herrmann*,a, Aaron Ciechanoverb, Lilach O Lermanc and Amir Lermana

aDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
bRappaport Institute for Research in Medical Sciences, Technion-Israel Institue of Technology, Haifa, Israel
cDivision of Hypertension, Mayo Clinic, Rochester, MN, USA

* Corresponding author. Department of Internal Medicine, Mayo Clinic Rochester, 200 First Street SW, Rochester, MN 55905, USA. Tel.: +1-507-255-5890; fax: +1-507-255-1824. herrmann.joerg{at}mayo.edu

During recent years, the ubiquitin–proteasome system has become known as the major pathway of non-lysosomal degradation of intracellular proteins, involving two sequential steps. In the first step, multiple moieties of ubiquitin are covalently bound to target proteins to be recognized and degraded by the multi-enzymatic proteasome complex in the second step. In addition to the elimination of damaged and unneeded proteins, this system fulfills an important function in the regulation of cellular mediators in various biological pathways. Foremost, these biological pathways include inflammation, cell proliferation, and apoptosis, all of which constitute important characteristics of atherosclerosis. Indeed, recent experimental evidence supports a potential involvement of the ubiquitin–proteasome system in the initiation, progression, and complication stage of atherogenesis. This review summarizes recent findings regarding the ubiquitin–proteasome system in cardiovascular diseases and discusses the potential use of proteasome inhibitors in cardiovascular therapy.

KEYWORDS Apoptosis; Atherosclerosis; Coronary disease; Restenosis

Time for primary review 29 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. Gao, J. Zhang, X. Si, J. Wong, C. Cheung, B. McManus, and H. Luo
Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H401 - H408.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
R. Marfella, C. Di Filippo, M. Portoghese, F. Ferraraccio, B. Crescenzi, M. Siniscalchi, M. Barbieri, C. Bologna, M. R. Rizzo, F. Rossi, et al.
Proteasome Activity as a Target of Hormone Replacement Therapy-Dependent Plaque Stabilization in Postmenopausal Women
Hypertension, April 1, 2008; 51(4): 1135 - 1141.
[Abstract] [Full Text] [PDF]

Home page
 Nutr Clin PractHome page
G. P. Zaloga and R. Siddiqui
A Soluble ATP-Dependent Proteolytic System Is Responsible for Protein Degradation
Nutr Clin Pract, February 1, 2006; 21(1): 88 - 91.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.